Bhatnagar V - Search Results

1

FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma.

Chang E, Weinstock C, Zhang L, Fiero MH, Zhao M, Zahalka E, Ricks TK, Fourie Zirkelbach J, Qiu J, Yu J, Chen XH, Bhatnagar V, Goldberg KB, Tang S, Kluetz PG, Pazdur R, Ibrahim A, Beaver JA, Amiri-Kordestani L. Chang E, et al. Among authors: bhatnagar v. Clin Cancer Res. 2022 Feb 1;28(3):441-445. doi: 10.1158/1078-0432.CCR-21-2334. Epub 2021 Aug 20. Clin Cancer Res. 2022. PMID: 34417198 Free PMC article.

2

FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy.

Bhatnagar V, Gormley NJ, Luo L, Shen YL, Sridhara R, Subramaniam S, Shen G, Ma L, Shord S, Goldberg KB, Farrell AT, McKee AE, Pazdur R. Bhatnagar V, et al. Oncologist. 2017 Nov;22(11):1347-1353. doi: 10.1634/theoncologist.2017-0229. Epub 2017 Sep 13. Oncologist. 2017. PMID: 28904172 Free PMC article. Clinical Trial.

3

Analyzing patient-reported outcome data when completion differs between arms in open-label trials: an application of principal stratification.

Roydhouse JK, Gutman R, Bhatnagar V, Kluetz PG, Sridhara R, Mishra-Kalyani PS. Roydhouse JK, et al. Among authors: bhatnagar v. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1386-1394. doi: 10.1002/pds.4875. Epub 2019 Aug 13. Pharmacoepidemiol Drug Saf. 2019. PMID: 31410963

4

FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.

King-Kallimanis BL, Wroblewski T, Kwitkowski V, De Claro RA, Gwise T, Bhatnagar V, Farrell AT, Kluetz PG. King-Kallimanis BL, et al. Among authors: bhatnagar v. Qual Life Res. 2020 Jul;29(7):1903-1911. doi: 10.1007/s11136-020-02448-y. Epub 2020 Feb 25. Qual Life Res. 2020. PMID: 32100182

5

The Evolution of Clinical Trials in Metastatic Breast Cancer: Design Features and Endpoints That Matter.

Seidman AD, Maues J, Tomlin T, Bhatnagar V, Beaver JA. Seidman AD, et al. Among authors: bhatnagar v. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-11. doi: 10.1200/EDBK_280451. Am Soc Clin Oncol Educ Book. 2020. PMID: 32223668 Free article.

6

Patient-Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019.

Bhatnagar V, Hudgens S, Piault-Louis E, Jones L, Beaver JA, Lyerly HK, Reaman G, Fleming T, Kluetz PG. Bhatnagar V, et al. Oncologist. 2020 Oct;25(10):819-821. doi: 10.1634/theoncologist.2020-0062. Epub 2020 Jun 9. Oncologist. 2020. PMID: 32463153 Free PMC article.

7

Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials.

Kluetz PG, King-Kallimanis BL, Suzman D, Chang E, Brave MM, Weinstock C, Bhatnagar V, Beaver JA, Chuk MK. Kluetz PG, et al. Among authors: bhatnagar v. J Natl Cancer Inst. 2021 May 4;113(5):507-508. doi: 10.1093/jnci/djaa135. J Natl Cancer Inst. 2021. PMID: 32857840 Free PMC article. No abstract available.

8

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer.

Gao JJ, Osgood CL, Gong Y, Zhang H, Bloomquist EW, Jiang X, Qiu J, Yu J, Song P, Rahman NA, Chiu HJ, Ricks TK, Rizvi F, Hou S, Wilson W, Abukhdeir AM, Seidman J, Ghosh S, Philip R, Pierce WF, Bhatnagar V, Kluetz PG, Pazdur R, Beaver JA, Amiri-Kordestani L. Gao JJ, et al. Among authors: bhatnagar v. Clin Cancer Res. 2021 Apr 15;27(8):2126-2129. doi: 10.1158/1078-0432.CCR-20-3474. Epub 2020 Nov 13. Clin Cancer Res. 2021. PMID: 33188141

9

The FDA's patient-focused drug development initiative.

Kluetz PG, Bhatnagar V. Kluetz PG, et al. Among authors: bhatnagar v. Clin Adv Hematol Oncol. 2021 Feb;19(2):70-72. Clin Adv Hematol Oncol. 2021. PMID: 33596186 No abstract available.

10

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma.

Casey D, Demko S, Sinha A, Mishra-Kalyani PS, Shen YL, Khasar S, Goheer MA, Helms WS, Pan L, Xu Y, Fan J, Leong R, Liu J, Yang Y, Windsor K, Ou M, Stephens O, Oh B, Reaman GH, Nair A, Shord SS, Bhatnagar V, Daniels SR, Sickafuse S, Goldberg KB, Theoret MR, Pazdur R, Singh H. Casey D, et al. Among authors: bhatnagar v. Clin Cancer Res. 2021 Aug 1;27(15):4142-4146. doi: 10.1158/1078-0432.CCR-20-5032. Epub 2021 Mar 12. Clin Cancer Res. 2021. PMID: 33712511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,040 results

Search Page

Filters